首页> PloS one> Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia.

Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia.

导出 OA

翻译打印收藏纠错

第一作者： Alessandra,Cesano

第一单位： Nodality, Inc., South San Francisco, California, United States of America.

作者： Alessandra,Cesano ^[1] ; Cheryl L,Willman ^[2] ; Kenneth J,Kopecky ^[3] ; Urte,Gayko ^[1] ; Santosh,Putta ^[1] ; Brent,Louie ^[1] ; Matt,Westfall ^[1] ; Norman,Purvis ^[1] ; David C,Spellmeyer ^[1] ; Carol,Marimpietri ^[1] ; Aileen C,Cohen ^[1] ; James,Hackett ^[1] ; Jing,Shi ^[1] ; Michael G,Walker ^[1] ; Zhuoxin,Sun ^[4] ; Elisabeth,Paietta ^[5] ; Martin S,Tallman ^[6] ; Larry D,Cripe ^[7] ; Susan,Atwater ^[8] ; Frederick R,Appelbaum ^[9] ; Jerald P,Radich ^[9]

作者单位： Nodality, Inc., South San Francisco, California, United States of America. ^[1] University of New Mexico Cancer Center, Albuquerque, New Mexico, United States of America. ^[2] SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. ^[3] ECOG Coordinating Center, Frontier Science, Boston, Massachusetts, United States of America. ^[4] Montefiore Medical Center North Division, Bronx, New York, United States of America. ^[5] Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. ^[6] Indiana University Simon Cancer Center, Indianapolis, Indiana, United States of America. ^[7] Stanford University, Palo Alto, California, United States of America. ^[8] Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. ^[9]